Navigation Links
Mast Therapeutics Reports First Quarter 2013 Financial Results

ss releases and periodic filings with the Securities and Exchange Commission. The Company's public filings with the Securities and Exchange Commission are available at

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. Mast Therapeutics does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.

[Tables to Follow]

 Mast Therapeutics, Inc(A Development Stage Enterprise)Condensed Consolidated Statements of Operations(In thousands except per share data)Three months endedMarch 31,(Unaudited)20132012Total net revenue


8212;Operating expenses:Research and development


2,210Selling, general and administrative


2,045Transaction-related expenses


(114)Depreciation and amortization


30Total operating expenses


4,171Loss from operations


(4,171)Interest and other income, net


18Net loss


Net loss per share – basic and diluted


Weighted average shares – basic and diluted


47,716 Mast Therapeutics, Inc(A Development Stage Enterprise)Balance Sheet Data(In thousands)March

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
(Date:10/9/2015)...  The Centers for Disease Control and Prevention, ... Infectious Diseases, Office of Advanced Molecular Detection (OAMD), ... collaboration to evaluate the performance of Edico Genome,s ... collaboration is to evaluate the utility of the ... infectious disease applications. This collaboration will also focus ...
(Date:10/9/2015)...  Hi-Tech Pharmaceuticals ("Hi-Tech"), a leading global provider ... ("iForce"), one of the fastest-growing Sports Nutrition companies ... today announced that they have entered into a ... acquire iForce. The transaction will enhance Hi-Tech,s leading ... iForce,s strong distribution network. Jared Wheat ...
(Date:10/9/2015)...   --> --> Phase ... San Diego, California , by Dr. Tom Lyon , ... Center, on 9 th October 2015 at 8:30a.m. PDT. ... Tom Lyon , Director of Orthopaedics and Chief of Orthopaedic Trauma, ... 8:30a.m. PDT. --> Kuros Biosurgery AG, a biotechnology company ...
Breaking Medicine Technology:
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:
(Date:10/9/2015)... LA (PRWEB) , ... October 09, 2015 , ... ... offices serving New Orleans and the surrounding communities, is initiating a combined charity ... medical care for unwanted animals in southern Louisiana. , Animal Rescue New ...
(Date:10/9/2015)... ... October 09, 2015 , ... MMJ PhytoTech Limited ... Ed Begley Jr., airing 1st QT 2016 via the Discovery Channel. Dates and ... Phytotech Limited (MMJ) – a global leader in the field of commercializing medicinal ...
(Date:10/9/2015)... ... 09, 2015 , ... Ryan Fox, the founder and CEO ... Colorado, says the latest figures on the state’s sales of legalized marijuana acknowledge ... industry. , Last month, according to the website , Colorado's ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Most people ... processed with more vegetables and less meat. While noted T’ai Chi Master and integrative ... “Yin and Yang” relationship between the two cuisines and that they potentially complement one ...
(Date:10/9/2015)... ... , ... A variety of race options will be available for the Run 4 Recovery sponsored ... at Al Lopez Park, 4810 North Himes Avenue, in Tampa. The family friendly event will ... run or walk and a one-mile walk, followed by an award ceremony at 10 a.m. ...
Breaking Medicine News(10 mins):
... Systems, Inc. (MDS), a national leader in accounts receivable management, and ... to the newly created position of Chief Operating Officer (COO). ... ... healthcare receivables industry leader, MDS ( ), has announced Eugene ...
... House made the correct decision to withdraw its ... have military veterans, personal insurance companies pay for ... Ryan, Jr., USN-Ret., president of the Military Officers ... President Obama that "pursuing this insurance proposal would ...
... - Estimated one-year, recurrence-free survival was 98% for Kit-positive ... placebo(1)- Historically, one in two patients experienced recurrence of ... - Gleevec is the only treatment in the US ... GIST after surgery; regulatory review is underway in the ...
... ANN ARBOR, Mich.---Scientists are closer to understanding which proteins ... exercise. This understanding could lead to new drug therapies ... and other health problems associated with having high blood ... by the body doesn,t properly stimulate the transport of ...
... 18 Askesis Development Group, Inc., a leader ... treatment, and social services markets, is pleased to ... enhanced features are focused on creating a completely ... comprehensive electronic medical record (EMR), and streamlined revenue ...
... 18 Bionovo, Inc. (Nasdaq: BNVI ), a ... in women,s health and oncology, today announced that Isaac Cohen, ... Wall Street Analyst Forum,s 20th Annual Institutional Investor Conference at ... will be held at the University Club in New York ...
Cached Medicine News:
... full length 10" elastic binder has a variety ... as an abdominal binder for post-surgical dressings. ... there has been a loss of muscle tone. ... rib belt to prevent painful expansion of the ...
Designed to provide relief from chronic or acute back pain by unloading pressure off the lumbar discs and shifting pressure to the abdominal region...
... consists of an anterior thoracic and pelvic ... serrated discs on the superior and inferior ... uprights are padded and adjustable in length. ... thoracic extensions.,Biomechanics: B.O.S.S. L-25A controls flexion with ...
Effectively stabilize and relax your back with the LumboTrain back support....
Medicine Products: